MetaCap

Claritev Corporation Class A (CTEV)

NYSE: CTEVConsumer DiscretionaryBusiness ServicesUSD

18.28-0.75 (-3.94%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CTEV stock chart

Technical analysis

Key statistics

All statistics
Market cap
$312.13M
EPS (TTM)
-$16.41
52-week range
11.50 – 55.50
Day range
18.01 – 20.32
Volume / Avg
246.94K / 210.93K
Beta
—

52-week range

$11.50$55.50

CTEV stock today

On Nov 20, CTEV ended the session at $18.28, shedding $0.75 (3.94%), versus the S&P 500's 3.70% decline. At this level, CTEV sits near the bottom of its 52-week range of $11.50 to $55.50: 67.1% below the high, set on Nov 28, 2025 and 59.0% above the low. CTEV is down 57.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 61.2%.

Claritev has posted a net loss over the last twelve months (EPS of -$16.41), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Claritev

Company profile

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services.

Industry
Business Services
CEO
Mr. Travis S. Dalton
Headquarters
McLean, VA
Employees
3,000
IPO year
2020

Financial highlights

Full financials

In fiscal 2025, Claritev generated $965.4 million in revenue, up 3.7% from fiscal 2024. Claritev reported a net loss of $284.3 million, compared with a loss of $1.65 billion a year earlier. Gross margin was 73.8% (down from 74.3%) and operating margin 3.0%.

Claritev annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$965.41M$930.62M$961.52M$1.08B$1.12B
Growth+3.74%-3.21%-10.95%-3.39%+19.18%
Net income$-284.28M$-1.65B$-91.70M$-572.91M$102.08M
EPS (diluted)$-17.30$-101.92$-5.69$-0.90$0.16

Analyst forecast

Forecast

Consensus (5 analysts)

buy

Avg. price target

$48.60+165.86%

  • Strong buy 2
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $30.00High $82.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 9, 2026
EPS actual vs est.
$-4.07 vs $-3.68
Surprise
-10.60%

CTEV news

All CTEV news

Claritev peers

Consumer Discretionary sector
CTEV peer companies
CompanyPrice% ChgMarket capCompare
ADVAdvantage Solutions Inc. Class A24.63-4.39%$314.50Mvs CTEV
ALITAlight Inc. Class A9.34-1.79%$348.58Mvs CTEV
RPAYRepay Holdings Corporation Class A3.83-4.49%$363.92Mvs CTEV
FVRRFiverr International Ltd.7.23-1.77%$259.92Mvs CTEV
CURRCurrenc Group Inc.1.89+1.07%$212.21Mvs CTEV
RYDERyde Group Ltd. Class A1.07-9.32%$192.84Mvs CTEV
AMWLAmerican Well Corporation Class A10.75+0.56%$185.12Mvs CTEV
RMNIRimini Street Inc. (DE)4.75-9.35%$440.31Mvs CTEV

Indexes, lists and sector

Claritev stock FAQ

What is Claritev's stock price today?

CTEV last traded at $18.28 as of Nov 20, 4:00 PM EST, down 3.94% on the day. Prices are delayed at least 15 minutes.

Does Claritev pay a dividend?

No. Claritev does not currently pay a regular cash dividend.

Who is Claritev's CEO?

Mr. Travis S. Dalton is the chief executive officer of Claritev Corporation Class A, which has about 3,000 employees.

Has CTEV ever split its stock?

Yes. The most recent CTEV stock split was a 1-for-40 split on Sep 23, 2024.

What is the CTEV 52-week high?

The 52-week high for CTEV is $55.50 and the 52-week low is $11.50. The stock is currently 67.1% below its high.

Compare CTEV